Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
added, analytical, anticancer, Bay, belonging, billion, biomedical, bivatuzumab, borne, CanAg, confirmed, diagnosed, EITF, electronically, exploit, exploiting, expressly, external, extra, FAS, fermentation, filer, FIN, fixed, gave, half, herewith, IDEC, inclusion, insufficient, judgment, leg, lifetime, linker, living, MA, Marsden, Mary, McCann, merged, Northeastern, occupy, outlicense, Park, path, people, point, preexisting, procure, prominent, prospective, regain, regained, rejoined, relicense, relicensing, relinquish, resemble, residing, Rituxan, Rituximab, rolling, Rule, run, semisynthetic, sending, Springfield, Sr, subheadingCommon, succeed, Task, taxane, tender, trastuzumab, unconditional, unconjugated, unexercised, unidentified, usage, website, Weston, written
Removed:
Academy, Advisory, amortization, amortized, authority, began, Biology, Boston, California, Certificate, colon, conform, Consent, consisting, credited, evaluated, Evan, extending, finder, fund, Gerard, Harvard, Head, implemented, inadequate, mammalian, managed, member, noted, programmed, proliferation, regimen, reliance, residual, retroactive, Richard, Schlossman, standard, subleased, traditionally, venture
Filing tables
Filing exhibits
IMGN similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
EXHIBIT 21
ImmunoGen Securities Corp., a Massachusetts corporation
Apoptosis Technology, Inc., a Massachusetts corporation
SUBSIDIARIES